Home › NDC Lookup › RxCUI directory › RxCUI 1308569

24 HR rivastigmine 0.554 MG/HR Transdermal System — RxCUI 1308569

RxNorm drug concept · Semantic clinical drug
RxCUI 1308569 Semantic clinical drug · SCD ● Current RxNorm concept 29 FDA products 29 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1308569
Official name24 HR rivastigmine 0.554 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrivastigmine 13.3 MG/Day 24HR Transdermal Patch; rivastigmine 13.3 MG/Day 24HR Transdermal System
FDA products mapped29
Package NDCs mapped29
Reported Medicaid activity (SDUD)5,404 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rivastigmine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's not a cure, and it won't stop the disease from progressing. What it does is help the brain hold on to more of a chemical called acetylcholine, which plays a big role in memory...
  • What exactly does rivastigmine do — is it a cure for Alzheimer's or Parkinson's dementia?
  • They work through the same mechanism, but they're approved for slightly different things. The patch forms (like Exelon) are approved for mild, moderate, and severe Alzheimer's dise...
  • What's the difference between the patch and the capsule — does one work better?
📖 Read our full Rivastigmine guide →

🕸️ Concept Web — How 24 HR rivastigmine 0.554 MG/HR Transdermal Syste... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR rivastigmine 0.554 MG/HR Transdermal System RxCUI 1308569

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rivastigmine 183379
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Exelon 225807
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rivastigmine Transdermal System 1805978
    • Rivastigmine Topical Product 1157973
    • Rivastigmine Transdermal Product 1295358
    • Rivastigmine Transdermal System [Exelon] 1805980
    • Exelon Topical Product 1173234
    • Exelon Transdermal Product 1296125
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rivastigmine 0.554 MG/HR SCDC · 1308568
  • Rivastigmine Transdermal System SCDF · 1805978
  • Rivastigmine Topical Product SCDG · 1157973
  • Rivastigmine Transdermal Product SCDG · 1295358

Brand-Name Concepts

📦 FDA Products & Package NDCs

29 products · 29 package NDCs
29 package NDCs map to RxCUI 1308569 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0501-15 30 PATCH in 1 CARTON (0078-0501-15) / 24 h in 1 PATCH (0078... Exelon Novartis Pharmaceuticals Corporation 2007-07-06
00078-0502-15 30 PATCH in 1 CARTON (0078-0502-15) / 24 h in 1 PATCH (0078... Exelon Novartis Pharmaceuticals Corporation 2007-07-06
00078-0503-15 30 PATCH in 1 CARTON (0078-0503-15) / 24 h in 1 PATCH (0078... Exelon Novartis Pharmaceuticals Corporation 2007-07-06
00378-9070-93 30 POUCH in 1 CARTON (0378-9070-93) / 1 PATCH in 1 POUCH (0... Rivastigmine Mylan Pharmaceuticals Inc. 2018-06-20
00378-9071-93 30 POUCH in 1 CARTON (0378-9071-93) / 1 PATCH in 1 POUCH (0... Rivastigmine Mylan Pharmaceuticals Inc. 2018-06-20
00378-9072-93 30 POUCH in 1 CARTON (0378-9072-93) / 1 PATCH in 1 POUCH (0... Rivastigmine Mylan Pharmaceuticals Inc. 2018-06-20
00781-7304-31 30 PATCH in 1 CARTON (0781-7304-31) / 24 h in 1 PATCH (0781... Rivastigmine Sandoz Inc 2015-09-02
00781-7309-31 30 PATCH in 1 CARTON (0781-7309-31) / 24 h in 1 PATCH (0781... Rivastigmine Sandoz Inc 2015-09-02
00781-7313-31 30 PATCH in 1 CARTON (0781-7313-31) / 24 h in 1 PATCH (0781... Rivastigmine Sandoz Inc 2015-09-02
16714-0116-02 30 POUCH in 1 CARTON (16714-116-02) / 24 h in 1 POUCH (1671... Rivastigmine Northstar Rx LLC. 2019-10-01
16714-0117-02 30 POUCH in 1 CARTON (16714-117-02) / 24 h in 1 POUCH (1671... Rivastigmine Northstar Rx LLC. 2019-10-01
51991-0897-30 30 POUCH in 1 CARTON (51991-897-30) / 1 PATCH in 1 POUCH (5... Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc. 2019-12-19
51991-0898-30 30 POUCH in 1 CARTON (51991-898-30) / 1 PATCH in 1 POUCH (5... Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc. 2019-12-19
51991-0899-30 30 POUCH in 1 CARTON (51991-899-30) / 1 PATCH in 1 POUCH (5... Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc. 2019-12-19
63629-2064-01 30 POUCH in 1 CARTON (63629-2064-1) / 1 PATCH in 1 POUCH (6... Rivastigmine Transdermal System Bryant Ranch Prepack 2021-02-11
63629-8846-01 30 POUCH in 1 CARTON (63629-8846-1) / 1 PATCH in 1 POUCH (6... Rivastigmine Transdermal System Bryant Ranch Prepack 2021-09-20
65162-0749-34 30 PATCH in 1 CARTON (65162-749-34) / 24 h in 1 PATCH Rivastigmine Amneal Pharmaceuticals LLC 2015-06-30
65162-0825-34 30 PATCH in 1 CARTON (65162-825-34) / 24 h in 1 PATCH Rivastigmine Amneal Pharmaceuticals LLC 2015-06-30
65162-0826-34 30 PATCH in 1 CARTON (65162-826-34) / 24 h in 1 PATCH Rivastigmine Amneal Pharmaceuticals LLC 2015-06-30
66758-0142-31 30 PATCH in 1 CARTON (66758-142-31) / 24 h in 1 PATCH (6675... Exelon Sandoz Inc 2025-10-03
66758-0143-31 30 PATCH in 1 CARTON (66758-143-31) / 24 h in 1 PATCH (6675... Exelon Sandoz Inc 2025-10-03
66758-0144-31 30 PATCH in 1 CARTON (66758-144-31) / 24 h in 1 PATCH (6675... Exelon Sandoz Inc 2025-10-03
70710-1196-07 30 POUCH in 1 CARTON (70710-1196-7) / 24 h in 1 POUCH (7071... Rivastigmine Zydus Pharmaceuticals USA Inc. 2019-03-06
70710-1197-07 30 POUCH in 1 CARTON (70710-1197-7) / 24 h in 1 POUCH (7071... Rivastigmine Zydus Pharmaceuticals USA Inc. 2019-03-06
70710-1198-07 30 POUCH in 1 CARTON (70710-1198-7) / 24 h in 1 POUCH (7071... Rivastigmine Zydus Pharmaceuticals USA Inc. 2019-03-06
70771-1949-07 30 POUCH in 1 CARTON (70771-1949-7) / 24 h in 1 POUCH (7077... Rivastigmine Zydus Lifesciences Limited 2019-03-06
70771-1950-07 30 POUCH in 1 CARTON (70771-1950-7) / 24 h in 1 POUCH (7077... Rivastigmine Zydus Lifesciences Limited 2019-03-06
70771-1951-07 30 POUCH in 1 CARTON (70771-1951-7) / 24 h in 1 POUCH (7077... Rivastigmine Zydus Lifesciences Limited 2019-03-06
72162-1610-03 30 POUCH in 1 CARTON (72162-1610-3) / 1 PATCH in 1 POUCH /... Rivastigmine Transdermal System Bryant Ranch Prepack 2024-12-24
Observed labelers: Sandoz Inc (6) · Amneal Pharmaceuticals LLC (3) · Breckenridge Pharmaceutical, Inc. (3) · Bryant Ranch Prepack (3) · Mylan Pharmaceuticals Inc. (3) · Novartis Pharmaceuticals Corporation (3) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.